Cargando…
Pharmacology and physiology of gastrointestinal enteroendocrine cells
Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretio...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506687/ https://www.ncbi.nlm.nih.gov/pubmed/26213627 http://dx.doi.org/10.1002/prp2.155 |
_version_ | 1782381726383734784 |
---|---|
author | Mace, O J Tehan, B Marshall, F |
author_facet | Mace, O J Tehan, B Marshall, F |
author_sort | Mace, O J |
collection | PubMed |
description | Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretion involve multiple nutrient transporters and G protein-coupled receptors (GPCRs), which are activated simultaneously under prevailing nutrient conditions in the intestine following a meal. The majority of studies investigate hormone secretion from EECs in response to single ligands and although the mechanisms behind how individual signaling pathways generate a hormonal output have been well characterized, our understanding of how these signaling pathways converge to generate a single hormone secretory response is still in its infancy. However, a picture is beginning to emerge of how nutrients and full, partial, or allosteric GPCR ligands differentially regulate the enteroendocrine system and its interaction with the enteric and central nervous system. So far, activation of multiple pathways underlies drug discovery efforts to harness the therapeutic potential of the enteroendocrine system to mimic the phenotypic changes observed in patients who have undergone Roux-en-Y gastric surgery. Typically obese patients exhibit ∼30% weight loss and greater than 80% of obese diabetics show remission of diabetes. Targeting combinations of enteroendocrine signaling pathways that work synergistically may manifest with significant, differentiated EEC secretory efficacy. Furthermore, allosteric modulators with their increased selectivity, self-limiting activity, and structural novelty may translate into more promising enteroendocrine drugs. Together with the potential to bias enteroendocrine GPCR signaling and/or to activate multiple divergent signaling pathways highlights the considerable range of therapeutic possibilities available. Here, we review the pharmacology and physiology of the EEC system. |
format | Online Article Text |
id | pubmed-4506687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45066872015-07-24 Pharmacology and physiology of gastrointestinal enteroendocrine cells Mace, O J Tehan, B Marshall, F Pharmacol Res Perspect Invited Reviews Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretion involve multiple nutrient transporters and G protein-coupled receptors (GPCRs), which are activated simultaneously under prevailing nutrient conditions in the intestine following a meal. The majority of studies investigate hormone secretion from EECs in response to single ligands and although the mechanisms behind how individual signaling pathways generate a hormonal output have been well characterized, our understanding of how these signaling pathways converge to generate a single hormone secretory response is still in its infancy. However, a picture is beginning to emerge of how nutrients and full, partial, or allosteric GPCR ligands differentially regulate the enteroendocrine system and its interaction with the enteric and central nervous system. So far, activation of multiple pathways underlies drug discovery efforts to harness the therapeutic potential of the enteroendocrine system to mimic the phenotypic changes observed in patients who have undergone Roux-en-Y gastric surgery. Typically obese patients exhibit ∼30% weight loss and greater than 80% of obese diabetics show remission of diabetes. Targeting combinations of enteroendocrine signaling pathways that work synergistically may manifest with significant, differentiated EEC secretory efficacy. Furthermore, allosteric modulators with their increased selectivity, self-limiting activity, and structural novelty may translate into more promising enteroendocrine drugs. Together with the potential to bias enteroendocrine GPCR signaling and/or to activate multiple divergent signaling pathways highlights the considerable range of therapeutic possibilities available. Here, we review the pharmacology and physiology of the EEC system. John Wiley & Sons, Ltd 2015-08 2015-07-07 /pmc/articles/PMC4506687/ /pubmed/26213627 http://dx.doi.org/10.1002/prp2.155 Text en © 2015 The Heptares Therapeutics. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Invited Reviews Mace, O J Tehan, B Marshall, F Pharmacology and physiology of gastrointestinal enteroendocrine cells |
title | Pharmacology and physiology of gastrointestinal enteroendocrine cells |
title_full | Pharmacology and physiology of gastrointestinal enteroendocrine cells |
title_fullStr | Pharmacology and physiology of gastrointestinal enteroendocrine cells |
title_full_unstemmed | Pharmacology and physiology of gastrointestinal enteroendocrine cells |
title_short | Pharmacology and physiology of gastrointestinal enteroendocrine cells |
title_sort | pharmacology and physiology of gastrointestinal enteroendocrine cells |
topic | Invited Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506687/ https://www.ncbi.nlm.nih.gov/pubmed/26213627 http://dx.doi.org/10.1002/prp2.155 |
work_keys_str_mv | AT maceoj pharmacologyandphysiologyofgastrointestinalenteroendocrinecells AT tehanb pharmacologyandphysiologyofgastrointestinalenteroendocrinecells AT marshallf pharmacologyandphysiologyofgastrointestinalenteroendocrinecells |